Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 8, 2023

West-ward Pharms Int Company Profile

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

What is the competitive landscape for WEST-WARD PHARMS INT, and what generic and branded alternatives to WEST-WARD PHARMS INT drugs are available?

WEST-WARD PHARMS INT has thirty-four approved drugs.

There is one tentative approval on WEST-WARD PHARMS INT drugs.

Summary for West-ward Pharms Int

US Patents:	0
Tradenames:	31
Ingredients:	28
NDAs:	34

Drugs and US Patents for West-ward Pharms Int

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
West-ward Pharms Int	IRINOTECAN HYDROCHLORIDE	irinotecan hydrochloride	INJECTABLE;INJECTION	078753-001	Dec 24, 2008	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
West-ward Pharms Int	TORSEMIDE	torsemide	INJECTABLE;INJECTION	078007-001	Jun 11, 2008		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
West-ward Pharms Int	LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE	epinephrine; lidocaine hydrochloride	INJECTABLE;INJECTION	080406-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
West-ward Pharms Int	CYANOCOBALAMIN	cyanocobalamin	INJECTABLE;INJECTION	080515-002	Approved Prior to Jan 1, 1982	AP	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
West-ward Pharms Int	OCTREOTIDE ACETATE	octreotide acetate	INJECTABLE;INJECTION	076330-001	Apr 8, 2005	AP	RX	No	Yes		⤷ Try a Trial				⤷ Try a Trial
West-ward Pharms Int	PROMETHAZINE HYDROCHLORIDE	promethazine hydrochloride	INJECTABLE;INJECTION	083312-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca

Colorcon

Moodys

Boehringer Ingelheim

McKinsey

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.